Citadel Advisors »

Cytomx Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $428k 276k 1.55
2023-09-30 $127k 98k 1.29
2023-06-30 $94k 55k 1.72
2023-03-31 $454k 301k 1.51
2022-12-31 $769k 480k 1.60
2022-06-30 $641k 351k 1.83
2022-03-31 $112k 42k 2.64
2021-12-31 $503k 116k 4.33
2021-09-30 $52k 10k 5.05
2021-06-30 $5.0M 789k 6.33
2021-03-31 $7.5M 971k 7.73
2020-12-31 $1.2M 185k 6.41
2020-09-30 $1.9M 281k 6.65
2020-06-30 $567k 68k 8.33
2020-03-31 $1.5M 202k 7.66
2019-12-31 $3.6M 436k 8.31
2019-09-30 $1.7M 233k 7.38
2019-03-31 $368k 34k 10.73
2018-09-30 $501k 27k 18.50
2018-06-30 $517k 23k 22.99
2018-03-31 $1.3M 47k 28.46
2017-06-30 $481k 31k 15.49
2017-03-31 $313k 18k 17.28